Antiphospholipid Syndromes and the Nervous System Clinical Features, Mechanisms, and Treatment
暂无分享,去创建一个
[1] B. Gårdlund. The lupus inhibitor in thromboembolic disease and intrauterine death in the absence of systemic lupus. , 2009, Acta medica Scandinavica.
[2] R. Brey. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke , 1993, Neurology.
[3] E. Mascha,et al. Factors that predict antiphospholipid immunoreactivity in young people with transient focal neurological events. , 1993, Archives of neurology.
[4] R. Adams,et al. Increased Immunoglobulin Binding to Cerebral Endothelium in Patients With Antiphospholipid Antibodies , 1993, Stroke.
[5] M. Rosove,et al. Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients , 1992, Annals of Internal Medicine.
[6] S. Levine,et al. Therapeutic Considerations for Stroke Patients With Antiphospholipid Antibodies , 1992, Stroke.
[7] S. Levine,et al. Risk of Recurrent Thromboembolic Events in Patients With Focal Cerebral Ischemia and Antiphospholipid Antibodies , 1992, Stroke.
[8] R. Abbate,et al. Lupus Anticoagulant and Anticardiolipin Antibodies in Young Adults With Cerebral Ischemia , 1992, Stroke.
[9] B. Coull,et al. Antiphospholipid Antibodies: Origin, Specificity, and Mechanism of Action , 1992, Stroke.
[10] D. Bridge,et al. Cerebral infarction complicating intravenous immunoglobulin therapy for polyneuritis cranialis , 1992, Neurology.
[11] M. Fisher,et al. Immunohematologic characteristics of infection-associated cerebral infarction. , 1991, Stroke.
[12] G. Hughes,et al. Antiphospholipid antibodies in cerebral ischemia. , 1991, Stroke.
[13] G. Hughes,et al. Phospholipid-Binding Antibodies , 1991 .
[14] M. Umeda,et al. Effective induction of anti-phospholipid and anticoagulant antibodies in normal mouse. , 1991, Thrombosis research.
[15] B. Coull,et al. Antiphospholipid antibodies, prethrombotic states, and stroke. , 1990, Stroke.
[16] L. Carreras,et al. Partial Neutralization of a Lupus Anticoagulant by Human Immunoglobulin , 1990, Thrombosis and Haemostasis.
[17] K. Welch,et al. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies , 1990, Neurology.
[18] D. Sherman,et al. Antiphospholipid antibodies and cerebral ischemia in young people , 1990, Neurology.
[19] M. Lockshin,et al. Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis. , 1990, The Journal of rheumatology.
[20] T. Koike,et al. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease , 1990, The Lancet.
[21] M. Mitchell,et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. , 1990, American journal of obstetrics and gynecology.
[22] A. Janoff,et al. Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[23] S. Barez,et al. Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus. , 1990, Annals of internal medicine.
[24] N. Pattison,et al. Corticosteroid treatment of pregnant women with antiphospholipid antibodies and previous fetal loss. , 1990, American Journal of Obstetrics and Gynecology.
[25] K. Calame,et al. Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus. , 1990, The Journal of clinical investigation.
[26] K. Elkon,et al. IgG anti-cardiolipin antibodies in murine lupus. , 1989, Clinical and experimental immunology.
[27] W. Wilson,et al. Cyclophosphamide use in a young woman with antiphospholipid antibodies and recurrent cerebrovascular accident. , 1989, Southern medical journal.
[28] G. Hughes,et al. The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features , 1989, Medicine.
[29] J. Sánchez-Guerrero,et al. Correction of thrombocytopenia with small dose aspirin in the primary antiphospholipid syndrome. , 1989, The Journal of rheumatology.
[30] J. Barquinero,et al. Fetal loss treatment in patients with antiphospholipid antibodies. , 1989, Annals of the rheumatic diseases.
[31] M. Fisher,et al. Cardiogenic brain embolism and lupus anticoagulant , 1989, Annals of neurology.
[32] J. Moreb,et al. Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: report of two cases. , 1989, The American journal of medicine.
[33] D. Fulcher,et al. PLASMA EXCHANGE AND THE ANTICARDIOLIPIN SYNDROME IN PREGNANCY , 1989, The Lancet.
[34] A. Patz,et al. Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). , 1989, Ophthalmology.
[35] M. Walport,et al. Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. , 1989, Annals of the rheumatic diseases.
[36] M. Lockshin,et al. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. , 1989, The American journal of medicine.
[37] A. Schorer,et al. Lupus anticoagulant induces a selective defect in thrombin‐mediated endothelial prostacyclin release and platelet aggregation , 1989, British journal of haematology.
[38] D. Briley,et al. Neurological disease associated with antiphospholipid antibodies , 1989, Annals of neurology.
[39] K. Digre,et al. Amaurosis fugax associated with antiphospholipid antibodies , 1989, Annals of neurology.
[40] M. Druzin,et al. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. , 1989, American journal of obstetrics and gynecology.
[41] K. Kalunian,et al. Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. , 1988, The American journal of medicine.
[42] K. Ward,et al. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. , 1988, American Journal of Obstetrics and Gynecology.
[43] T. Barbui,et al. INTRAVENOUS GAMMAGLOBULIN, ANTIPHOSPHOLIPID ANTIBODIES, AND THROMBOCYTOPENIA , 1988, The Lancet.
[44] B. Trudinger,et al. Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column. , 1988, Biochemical and biophysical research communications.
[45] D. Lillicrap,et al. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus. , 1988, The Journal of rheumatology.
[46] I. James,et al. Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus. , 1988, Annals of the rheumatic diseases.
[47] J. Brandt,et al. RELATIONSHIP BETWEEN LUPUS ANTICOAGULANTS AND ANTIBODIES TO PHOSPHOLIPID , 1988, Thrombosis and Haemostasis.
[48] K. Welch,et al. Ischemic stroke associated with anticardiolipin antibodies. , 1987, Stroke.
[49] D. Bourdette,et al. Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. , 1987, Stroke.
[50] R. Bennett,et al. An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: report of two cases. , 1987, Arthritis and rheumatism.
[51] D. Simel,et al. Correction of hypoprothrombinemia by immunosuppressive treatment of the lupus anticoagulant-hypoprothrombinemia syndrome. , 1987, The American journal of medicine.
[52] D. Anderson,et al. Recurrent cerebral ischemia and mitral valve vegetation in a patient with antiphospholipid antibodies. , 1987, The Journal of rheumatology.
[53] K. Welch,et al. The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies. , 1987, Archives of neurology.
[54] R. Derksen,et al. LACK OF EFFICACY OF PLASMA-EXCHANGE IN REMOVING ANTIPHOSPHOLIPID ANTIBODIES , 1987, The Lancet.
[55] O. Meyer,et al. [Anti-cardiolipin antibodies in Lyme disease]. , 1987, Revue du rhumatisme et des maladies osteo-articulaires.
[56] O. Nived,et al. Anticardiolipin antibodies in patients with systemic lupus erythematosus. , 1987, Arthritis and rheumatism.
[57] Obstetric complications associated with the lupus anticoagulant , 1986 .
[58] G. Hughes,et al. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. , 1986, Archives of internal medicine.
[59] L. Kater,et al. Discordant effects of prednisone on anticardiolipin antibodies and the lupus anticoagulant. , 1986, Arthritis and rheumatism.
[60] O. Vaarala,et al. Anticardiolipin response in acute infections. , 1986, Clinical immunology and immunopathology.
[61] M. Fisher,et al. Cerebral infarct, TIA, and lupus inhibitor , 1986, Neurology.
[62] S. Lipton,et al. Association of lupuslike anticoagulant and nonvasculitic cerebral infarction. , 1986, Archives of neurology.
[63] A. Grigg,et al. FATAL THROMBOTIC EVENTS DURING TREATMENT OF AUTOIMMUNE THROMBOCYTOPENIA WITH INTRAVENOUS IMMUNOGLOBULIN IN ELDERLY PATIENTS , 1986, The Lancet.
[64] G. Hughes,et al. Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal. , 1985, Annals of the rheumatic diseases.
[65] J. Scott,et al. Obstetric complications associated with the lupus anticoagulant. , 1985, The New England journal of medicine.
[66] M. A. Miller,et al. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. , 1985, Archives of internal medicine.
[67] R. Kelley,et al. Cerebral ischemia in the presence of lupus anticoagulant. , 1984, Archives of neurology.
[68] P. Yagnik,et al. Stroke and circulating lupus. , 1984, Stroke.
[69] A. Eldor,et al. Thromboembolism in patients with the 'lupus'-type circulating anticoagulant. , 1984, Archives of internal medicine.
[70] V. Bril,et al. Cerebral Infarction Associated with Lupus Anticoagulants - Preliminary Report , 1984, Stroke.
[71] G. Hughes,et al. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. , 1983, British medical journal.
[72] G. Liggins,et al. FETAL SURVIVAL AFTER PREDNISONE SUPPRESSION OF MATERNAL LUPUS-ANTICOAGULANT , 1983, The Lancet.
[73] G. Landi,et al. Recurrent ischemic attacks in two young adults with lupus anticoagulant. , 1983, Stroke.
[74] J. Vermylen,et al. “Lupus” Anticoagulant and Thrombosis – Possible Role of Inhibition of Prostacyclin Formation , 1982, Thrombosis and Haemostasis.
[75] R. Schwartz,et al. Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids , 1981, The Journal of experimental medicine.
[76] C. Stoddard,et al. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. , 1981, The New England journal of medicine.
[77] S. Rapaport,et al. Thrombosis in patients with the lupus anticoagulant. , 1980, Annals of internal medicine.
[78] E. Bowie,et al. THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS. , 1963, The Journal of laboratory and clinical medicine.
[79] C. Mohr,et al. Biologically false positive serologic tests for syphilis; type, incidence, and cause. , 1952 .
[80] S. Lindsay,et al. Studies on the Coagulation Defect in a Case of Thrombocytopenic Purpura Complicated by Thrombosis. , 1946, The American journal of pathology.
[81] M. C. Pangborn. A New Serologically Active Phospholipid from Beef Heart , 1941 .
[82] A. Wassermann,et al. Eine serodiagnostische Reaktion bei Syphilis , 1906 .
[83] D. Preston,et al. Cerebral Amyloid Angiopathy Associated With Giant Cell Arteritis : A Case Report , 2005 .
[84] Intravenous immunoglobulin: prevention and treatment of disease. Summary of the NIH Consensus Development Conference. , 1991, Transfusion medicine reviews.
[85] K. Fujikawa,et al. Placental anticoagulant protein-I: measurement in extracellular fluids and cells of the hemostatic system. , 1990, The Journal of laboratory and clinical medicine.
[86] NIH consensus conference. Intravenous immunoglobulin. Prevention and treatment of disease. , 1990, JAMA.
[87] G. Hughes,et al. Multiple small-vessel occlusions in systemic lupus erythematosus. , 1989, Stroke.
[88] H. Rus,et al. Lupus anticoagulant and transient severe bleeding tendency in a girl aged nine years. , 1988, Medecine interne.
[89] J. Brandt,et al. Lupus anticoagulants: misnomer, paradox, riddle, epiphenomenon. , 1988, Hematologic pathology.
[90] G. Hughes,et al. Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders. , 1988, The Journal of infectious diseases.
[91] T. Barbui,et al. INTERACTION BETWEEN LUPUS ANTICOAGULANT AND PLATELETS , 1987, Thrombosis and Haemostasis.
[92] J. Lewis,et al. Recurrent cerebral infarctions in two brothers with antiphospholipid antibodies that block coagulation reactions. , 1986, Stroke.
[93] K. Lechner,et al. Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. , 1985, Haemostasis.
[94] J. Garrick. Epidemiologic perspective. , 1982, Clinics in sports medicine.
[95] A. Loeliger,et al. Prothrombin as Co-Factor of the Circulating Anticoagulant in Systemic Lupus Erythematosus? , 1959, Thrombosis and Haemostasis.
[96] C. Conley. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus , 1952 .